FDA Approved: IBANDRONATE SODIUM — Original Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' ibandronate sodium as an original ANDA, enabling a generic product for osteoporosis in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)